Differentiating effect of oral administration of retinol palmitate (Chocola-A) for an aged AML (M3) with severe complications

J. Nomura, K. Endo, Kazumichi Furuyama, H. Harigae, A. Satou, T. Shishido, M. Okuda, T. Sugawara, K. Meguro, O. Fukuhara

研究成果: Article査読

抄録

A 74 year-old woman, who had been diagnosed as AML (M3) in poor condition, was treated with Retinol Palmitate (Chocola-A, 150,000 unit/m2 per os, after informed consent. An increase of white blood cells (neutrophil) counts was observed after 7 days. After 4 weeks, WBC counts were increased to 20,700/microliters (neutrophil counts 6,400/microliters) Maturation tendency of leukemic cells was also proved in the bone marrow. In vitro studies showed that morphological differentiation was recognizable in cultured leukemic cells treated with 10(-6)M all-trans retinoic acid after 6 days, but not in controls. Responses in the NBT reduction test were slightly less than in the clinical study. The administration of Retinol Palmitate may be a new regimen to treat AML (M3) in aged patients in poor condition.

本文言語English
ページ(範囲)1673-1678
ページ数6
ジャーナル[Rinshō ketsueki] The Japanese journal of clinical hematology
33
11
出版ステータスPublished - 1992 11

ASJC Scopus subject areas

  • 医学(全般)

フィンガープリント

「Differentiating effect of oral administration of retinol palmitate (Chocola-A) for an aged AML (M3) with severe complications」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル